Taken from the acquisition statement of Steifel Lab of Barrier, the firm Dr Geert founded:
Barrier Therapeutics is a pharmaceutical company focused on the development and commercialization of products in the field of dermatology.
Barrier Therapeutics currently markets three pharmaceutical products in the United States: Xolegel(R) (ketoconazole, USP) Gel, 2%, for seborrheic dermatitis; Vusion(R) (0.25% miconazole nitrate, 15% zinc oxide, 81.35% white petrolatum) Ointment, for diaper dermatitis complicated by documented
candidiasis; and Solage(R) (mequinol 2.0%, tretinoin 0.01%) Topical Solution, for solar lentigines. Barrier herapeutics has other product candidates in various stages of clinical development for the treatment of a range of dermatological conditions, including onychomycosis, psoriasis, acne, skin
allergies, and acute fungal infections.
http://www.reuters.com/article/2008/08/06/idUS250118+06-Aug-2008+PRN20080806
dr geert's old barrier therapeutics
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.508M | |||
| Open | High | Low | Value | Volume |
| 0.2¢ | 0.3¢ | 0.2¢ | $3.607K | 1.445M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 59 | 102396408 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 21041400 | 12 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| AVE (ASX) Chart |